Nasal glomus tumours are extremely rare neoplasms with poorly understood histogenesis, but which are clinically recognized as benign. The neoplastic cells of glomus tumours resemble normal glomus cells and are arranged around a varying number of thin-walled, sometimes branching, capillaries. CD34 is known to be a marker of tumour progenitor cells. In this report, two cases of benign nasal glomus tumour are presented. The tumours were excised completely via endoscopic endonasal surgery under local anaesthesia. During surgery, there was little bleeding and the post-surgical course for both patients was uneventful. Tumour cells from both cases were positive for a-smooth muscle actin, actin, vimentin and CD34 protein. Thus, CD34 positivity against a background of other immunohistochemical markers is helpful in the differential diagnosis of glomus tumours.
Introduction
Glomus tumours usually occur in the fingers, although extremely rarely they can also develop nasally. To our knowledge, only 28 cases of nasal glomus tumour have been reported in the English-language literature. 1 -9 Histologically, glomus tumours are composed of neoplastic cells resembling normal glomus cells arranged around a varying number of thin-walled, sometimes branching, capillaries. 10 Although the cell of origin is generally thought to be the pericyte, this has yet to be definitively confirmed. 10 − 14 Some studies have shown that neoplastic cells in glomus tumours clearly exhibit smooth-muscle characteristics such as the presence of muscle-specific actin (MSA) and α-smooth muscle actin (α-SMA), which has been demonstrated immunohistochemically and ultrastructurally. 13, 14 The neoplastic cells also exhibit properties of endothelial cells, 11, 12, 15 leading to the suggestion that the cell of origin in a glomus tumour is a transitional cell between endothelium and smooth muscle. 16, 17 Thus, the histogenesis of the glomus tumour is still a subject of active investigation.
CD34 is a marker of progenitor cells and CD34 + tumour development shares many features with that of endothelial cells, including responsiveness to mediators of endothelial cell growth. 18 An anti-CD34 antibody is a highly sensitive marker for endothelial-cell differentiation and has also Y-Y Xu, X-M Luo, S-H Zhou et al. CD34 and benign nasal glomus tumour been studied as a marker for vascular tumours. 18 In malignant tumours, the presence and distribution pattern of CD34 around tumour blood vessels is associated with early lymph node metastasis and death. 19, 20 Preliminary investigations have demonstrated CD34 immunoreactivity in the endothelial cells of benign and malignant glomus tumours, 2,10,11,21 − 25 but the role of the antigen in these tumours is unclear.
Here, two additional cases of benign nasal glomus tumour are reported, and the clinicopathological course of these tumours and the significance of positive immunohistochemical staining for CD34 in light of previously published reports, are discussed.
Case reports
Approval for the study was obtained from the Institutional Review Board of The First Affiliated Hospital, College of Medicine, Zhejiang University.
CLINICAL DATA

Case 1
A 38-year old man was admitted to the Department of Otolaryngology of The First Affiliated Hospital, College of Medicine, Zhejiang University, in February 2007. He described intermittent left nasal obstruction of 3 years' duration and a 1-month history of progressive obstruction without pain, olfactory dysfunction, headache or bleeding. He reported no significant alcohol or tobacco use. A mass in the left nasal septum had been found 17 months previously by the local county hospital and was diagnosed as a haemangioma. The patient was treated by the injection of hardeners (unknown drug or dose), but his symptoms persisted. Nasal endoscopic examination showed a red, soft, smooth lesion, 1.5 × 1.8 cm in size, at the anterior portion of the left nasal septum. 
EXCISION AND FOLLOW-UP
The tumours of both patients were excised completely, with little bleeding, via endoscopic endonasal surgery under local anaesthesia.
During surgery, an examination of frozen sections prepared from the two tumours suggested benign vascular tumours; the margins of the incisions were free. The post-operative course of each case was uneventful and the two patients were followed for 39 and 36 months, respectively, for case 1 and case 2. There has been no tumour recurrence in either patient.
HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL EVALUATION
Histological sections from both tumours were evaluated. Archival tissues obtained from institutional and consultation files were
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formalin-fixed and paraffin-embedded. One representative paraffin block from each tumour was selected for immunohistochemical study, performed using an EliVision™ Plus immuno histochemistry kit (Maixin Biological Technology, Fuzhou, China) as described previously. 26 Briefly, both specimens were examined immunohisto chemically for cytokeratin (CK), S-100 protein, CD68, vimentin, desmin, CD34, α-SMA and actin using commercial antibodies (Dako, Carpentaria, CA, USA). The antibodies and their dilutions are detailed in Table 1 . Antigen retrieval (as shown in Table 1 ) was carried out after the sections had been deparaffinized with xylene and dehydrated through an ethanol series. Endogenous peroxidase activity was blocked by incubating the slides in 1.5% hydrogen peroxide in absolute methanol at room Y-Y Xu, X-M Luo, S-H Zhou et al. CD34 and benign nasal glomus tumour temperature for 10 min. Sections were then incubated with primary antibodies for 1 h at room temperature, followed by the addition of 50 µl of polymer enhancer for 20 min and 50 µl of polymerized horseradish peroxidase-antimouse immunoglobulin G for 30 min at room temperature. After incubation with each antibody, sections were washed three times with 0.05 mol/l Trisbuffered saline (TBS), pH 7.2. Reaction products were visualized with diaminobenzidine (DAB kit; Fujian Maixin Biological Technology Ltd, Fujian, China), after which the sections were counterstained with haematoxylin and eosin, dehydrated and evaluated by light microscopy. TBS solution (10 mM, pH 7.4) was used in place of the primary antibody for negative controls. All stains were used as part of routine investigations and the antibodies were tested with suitable positive controls. The 1.5 × 1.8 cm specimen obtained from the patient in case 1 comprised dark-red, irregular, soft tissue. The cut surface showed a greyish and dark-red solid soft-tissue mass with multiple haemorrhagic spots. The 1.0 × 1.0 cm specimen obtained from the patient in case 2 consisted of greyish soft tissue with a bloody, encrusted surface.
Microscopically, both specimens contained nests of small, uniform, round glomus tumour cells with indistinct cell borders, surrounded by small blood vessels (Fig. 2) . The cell nuclei were sharply punched-out and rounded, and the cytoplasm was faintly eosinophilic (Fig. 3) . Additionally, the tumour cells were set in an intercellular matrix with prominent myxoid changes ( Fig. 4 ). No mitotic activity or cytological atypia were seen (Figs 3 and 4) .
Immunohistochemically, endothelial cells of the specimens were positive for CD34, with 5C ). Spindle-shaped myoid cells stained negative for desmin (data not shown). Both tumours were positive for vimentin ( Fig. 5D ) but not for S-100 protein, CK or CD68 (data not shown). The overall features were those of glomus tumours.
Discussion
Sinonasal glomus tumours are extremely rare. To our knowledge, fewer than 30 cases have been reported. 1 -9 The present report describes two additional cases of sinonasal glomus tumours. As also reported for digital glomus tumours, 7,24 previous reviews of nasal glomus tumours have found a female preponderance, with a ratio of females:males of approximately 2:1. 2 -4 Other extradigital glomus tumours appear to occur more commonly in males; 5 the two cases in the present report were male.
The symptoms of nasal glomus tumour include nasal obstruction, local pain, nasal bleeding and/or complaints of nasal mass. 1 − 6 In the present patient series, the clinical presentation was intermittent nasal obstruction or recurrent epistaxis. Lesions in 27 invasive glomus tumour 6, 8 and occasional recurrence of benign glomus tumour 5 in the sinonasal regions have, however, been reported.
On examination, the gross appearance of nasal glomus tumours may be confused with that of other more common vascular tumours, such as haemangioma or a nasal polyp. 3 Indeed, in case 1, the patient was diagnosed at a local hospital with a haemangioma. The exact diagnosis of glomus tumour depends on its histological and immunohistochemical features. The tumours have a distinct histological appearance, generally consisting of nests or aggregates of monotonous glomus-cell clusters with surrounding vessels. 6 Mitotic figures are typically absent. 28 An interesting aspect of a glomus tumour is its histogenesis. 10 − 17,28 − 30 It is widely accepted that the neoplastic cells in glomus tumours arise from the modified smoothmuscle cells that surround the arteriovenous anastomoses of the normal glomus body. 13, 14, 28, 31 This conclusion is based on the fact that, using immunohistochemical and ultrastructural techniques, 13 several studies have found tumour cells positive for vimentin and smooth MSA. 13, 14, 28, 31 Some studies have also reported that the cells of origin of glomus tumour are transitional cells, between endothelium and smoothmuscle cells, because glomus cells in the sinusoidal vessel walls are positive for both myoid (SMA, MSA) and vascular (CD31, CD34) markers. 16, 17, 30, 31 The biological significance of CD34 in the glomus tumours is noteworthy because human CD34 is a haematopoietic progenitor cell antigen. 19 It is a single-chain transmembrane glycoprotein with a molecular mass of 115 kDa. While CD34 is also present on the endothelial cells of vascular tumours, 12, 18, 25 only 10 publications in the English-language literature report its presence in glomus tumours. 2,10,11,21 − 25,32,33 The significance of CD34 in glomus tumours is controversial, as the number of reports is limited. Both of the current cases were positive for α-SMA, actin and CD34. In a 1993 study, Cohen et al. 34 did not find CD34 in two cases of glomus tumour. Hatori et al. 11 reported the presence of CD34 antibody in five of six cases of glomus tumour and suggested the potential utility of CD34 for its histological diagnosis. In a study of nasal glomus tumour, Chu et al. 2 reported focal CD34 positivity in two such tumours, whereas in the study by Abou Jaoude et al. 24 the two tumours that were positive for anti-CD34 antibody staining accounted for < 50% of their cases. Thus, the latter authors dismissed the hypothesis of an endothelial origin for the cells in glomus tumours in the absence of anti-CD34 antibody staining, and the specificity of anti-CD34 antibody to glomus tumours 5 could not be confirmed in their series. 24 Mentzel et al. 10 reported homogeneous positivity of neoplastic cells and endothelial cells for CD34, with concomitant positivity for α-SMA in all six cases of benign glomus tumour in which a myxoid matrix was prominent. They suggested that the presence of both actin and CD34 in a small subset of glomus tumours added support to the interpretation of these lesions as a family of perivascular neoplasms. 10 Pabuççuoglu et al. 22 also detected actin and CD34 co-staining in a glomus tumour with myxoid stroma, in addition to noting the presence of matrix metallopeptidase 9 (MMP-9) in the cells of this tumour. They suggested that the immunophenotypic changes enabling tumour cells to up-regulate MMP-9 was responsible for the myxoid stromal change 22 Thus, all these findings, including those from the two present cases, indicate that CD34 is a valuable marker in the differential diagnosis of glomus tumours.
Additionally, although malignant glomus tumours are rare, 6, 23, 27, 32, 35 their ability to upregulate CD34 has been studied. 23, 32 Skelton and Smith 23 reported a case of infiltrative glomus tumour arising from a benign glomus tumour, with CD34 detected in the circumscribed nodule. The pattern of CD34 staining within the infiltrative portion of the tumour was more diffuse in the single stromal cells surrounding the tumour cells, resulting in a lighter infiltrative staining pattern. 23 Although the deep location, size, vascular invasion and atypical mitotic figures observed in peripheral glomus tumours are significant indicators of malignancy, 32 Skelton and Smith 23 suggested CD34 as an additional marker for the locally aggressive behaviour and decreased differentiation that may characterize these tumours. Folpe et al. 32 found CD34 to be present in only five of 27 (19%) glomus tumours and did not comment specifically or provide further information regarding this observation. Thus, the significance of CD34 in malignant glomus tumours requires further investigation.
In conclusion, two cases of benign nasal glomus tumours are reported here. Both tumours were excised completely via endoscopic endonasal surgery under local anaesthesia, with little peri-operative bleeding. The post-operative course of the two patients was uneventful. In the two tumours, α-SMA, actin, vimentin and CD34 protein were present, suggesting that, against a background of other immunohistochemical markers, the presence of CD34 is helpful in the differential diagnosis of glomus tumours.
